On S100 proteins, the scientific literature to date has well emphasized their pro‐oncogenic in melanoma (namely, promoting metastatic colonization) and stressed the potential clinical utility of some of them, such as S100A8, S100A9, and S100B, as prognostic and predictive markers of therapeutic response in melanoma. This evidence concerns the gene S100A9 and melanoma.